Drugs / Antivenom Snakes
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07500233 Comparator | Jan 2027 → Oct 2028 expected | snakebite envenomation | Liverpool School of Tropical Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antivenom Snakes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07500233 ↗ |
| Route | Intravenous | “Standard of care IV antivenom recommended in country” NCT07500233 ↗ |